# Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution

> **NCT00025753** · NA · COMPLETED · sponsor: **National Center for Research Resources (NCRR)**

## Conditions studied

- HIV Infections
- Insulin Resistance

## Interventions

- **DRUG:** rosiglitazone (Avandia)
- **BEHAVIORAL:** Aerobic and weight lifting exercise training

## Key facts

- **NCT ID:** NCT00025753
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00025753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00025753, "Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00025753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*